• Pulmonary Exacerbations, Lung Dysfunction, And Eq-5d Measures In Adolescents And Adults With Cystic Fibrosis And Homozygous For The F508del-Cftr Mutation

    May 1, 2016, 00:00
  • Comparative Effectiveness of Panitumumab Versus Cetuximab In Patients With Chemo-Refractory Wild-Type Kras Metastatic Colorectal Cancer

    May 1, 2016, 00:00
  • The Association Between Smoking Status And Quality Of Life- Factoring In Lifestyle Variables

    May 1, 2016, 00:00
  • Selection Of The Most Appropriate Epro Mode- Contributing To The Success Of Patient-Centered Clinical Trials

    May 1, 2016, 00:00
  • Coverage of Pharmacogenomic Tests Among Minnesota Health Insurance Plans

    May 1, 2016, 00:00
  • Potential Drug-Drug Interactions in Pediatric Wards of Gondar University Hospital, Ethiopia- A Cross Sectional Study

    May 1, 2016, 00:00
  • COST BURDEN OF INAPPROPRIATE PROTON-PUMP INHIBITOR USE AMONG GASTROESOPHAGEAL REFLUX DISEASE PATIENTS

    May 1, 2016, 00:00
  • GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH ONCE-WEEKLY GLP-1RAS- COMPARISON OF A NETWORK META-ANALYSIS WITH A DIRECT ANALYSIS OF PLACEBO-CONTROLLED TRIALS

    May 1, 2016, 00:00
  • Time-To-Initiation, Healthcare Utilization, And Costs Of Treatment Of Attention Deficit Hyperactivity Disorder Among Texas Medicaid Preschoolers

    May 1, 2016, 00:00
  • Measuring The Economic Impact Of Ssb Taxes In Brazil- An Input-Output Analysis

    May 1, 2016, 00:00
  • A Global Economic Model to Assess the Cost Effectiveness of New Treatments for Advanced Breast Cancer in Canada

    May 1, 2016, 00:00
  • THE WAY OF LIFE, IN PARTICULAR THE IMPACT OF STRESS IN EMERGENCE OF GASTROINTESTINAL COMPLAINTS

    May 1, 2016, 00:00
  • CHARACTERISTICS AND OUTCOME OF NEWLY DIAGNOSED IMMUNE THROMBOCYTOPENIA IN ADULTS- RESULTS FROM THE PGRX INFORMATION SYSTEM

    May 1, 2016, 00:00
  • Economic Evaluation of School-Based Health Centers- A Community Guide Systematic Review

    May 1, 2016, 00:00
  • Estimation Of Direct And Indirect Costs Associated With Asthma And Copd- A Canadian Employers Perspective

    May 1, 2016, 00:00
  • A Cross-Sectional Survey of Community Pharmacists towards Antimicrobial Stewardship in Malaysia

    May 1, 2016, 00:00
  • Analysis of Real-World Database- Endometriosis Treatment Practice in Ukraine

    May 1, 2016, 00:00
  • Determinants And Distribution Of 18-24 Year Old Current Waterpipe Tobacco Smokers In The United States- Findings From The National Adult Tobacco Surveys

    May 1, 2016, 00:00
  • AN ASSESSMENT OF THE VALIDITY AND RESPONSIVENESS OF THE ICECAP-O IN A MULTICENTRE RANDOMIZED CONTROLLED TRIAL OF BLOOD PRESSURE MANAGEMENT

    May 1, 2016, 00:00
  • SF6D VALUE SETS- A SYSTEMATIC REVIEW

    May 1, 2016, 00:00
  • Real-World Cost Per Persisting Patient- Comparing Psoriasis Patients Initiated on Apremilast or Biologic Therapies

    May 1, 2016, 00:00
  • ECONOMIC BURDEN OF MANAGING HYPERGLYCEMIA IN ACROMEGALIC PATIENTS WHO WERE DIABETIC AT BASELINE TREATED WITH PASIREOTIDE

    May 1, 2016, 00:00
  • Oncologic Outcomes Of Metformin In Patients With Non-Metastatic Colon Cancer And Type 2 Diabetes In South Korea Using Nationwide Database

    May 1, 2016, 00:00
  • Impact of Disease Progression on Patient Reported Outcomes in Advanced Nsclc- Evidence from Patients Treated in Real World Community Oncology Settings

    May 1, 2016, 00:00
  • ADVERSE EVENTS ASSOCIATED WITH ANTIOBESITY MEDICATION USE- ANALYSIS OF THE FDA ADVERSE EVENT REPORTING SYSTEM FAERS 1997–2015

    May 1, 2016, 00:00
  • Estimating the Arthroplasties Revision Rates and Lifetime of Knee and Hip Prosthesis in the State of São Paulo, Brazil

    May 1, 2016, 00:00
  • Demographic Variance of Inpatient Hospitalizations from Stroke in the State of Missouri from 2000-2012

    May 1, 2016, 00:00
  • Government Reimbursement Values versus Real Chemotherapy Costs in the Brazilian Public Health Care System- Another Barrier to Treatment Access?

    May 1, 2016, 00:00
  • EFFICACY OF BIFIDOBACTERIUM INFANTIS 35624 IN PATIENTS WITH IRRITABLE BOWEL SYNDROME- A META-ANALYSIS

    May 1, 2016, 00:00
  • Health Care Costs among Men with Clinically Localized Prostate Cancer Managed with Observation Strategies Versus Immediate Treatment in an Integreated Health Care System

    May 1, 2016, 00:00
  • MARKET ACCESS AND PRICING ANALYSIS OF ULTRA-ORPHAN DRUGS

    May 1, 2016, 00:00
  • Marketing Authorization of Medicines Approved In Eu Via “Adaptive Pathway”- Consequences on The Egyptian Public Health

    May 1, 2016, 00:00
  • PREDICTORS OF MORTALITY AND CARDIOVASCULAR EVENTS IN PATIENTS NEWLY DIAGNOSED WITH TYPE 2 DIABETES MELLITUS

    May 1, 2016, 00:00
  • OUTCOME ASSESSMENTS OF PRIMARY ENDPOINTS OF NEW DRUGS APPROVED BY THE FDA (2011-2015)

    May 1, 2016, 00:00
  • Impact of Bupivacaine Liposomal Injectable Suspension on Hospital Length of Stay and Home Discharge among Medicare Patients Undergoing Total Knee Arthroplasty

    May 1, 2016, 00:00
  • Exploring Issues In Analyzing National Databases Using Logistic Regression- Application Of Medical Expenditure Panel Survey

    May 1, 2016, 00:00
  • Comparative Cost And Resource Utilization In Hospitalized Patients Treated With Unfractionated Heparin MonITORED By Anti-XA or APTT

    May 1, 2016, 00:00
  • Treatment Patterns In Medicaid Beneficiaries With Schizophrenia Reaching Stabilized Maintenance With Once-Monthly Paliperidone Palmitate Therapy

    May 1, 2016, 00:00
  • Comparative Estimation of the Out-of-Pocket Expenses and Indirect Costs Associated Ovarian Cancer and Parkinson’s Disease

    May 1, 2016, 00:00
  • MEASURING SATISFACTION LEVEL WITH HEALTH INSURANCE

    May 1, 2016, 00:00
  • Awareness and Impact of International Normalized Ratio Monitoring in Ongoing Anticoagulation Therapy in Cardiac Patients

    May 1, 2016, 00:00
  • Social Determinants of Young Pregnancy in Colombia

    May 1, 2016, 00:00
  • A Prevalence Study on Gestational Hypertension and Associated Complications in Pregnant Women

    May 1, 2016, 00:00
  • BUDGET IMPACT ANALYSIS OF VILDAGLIPTIN TREATING T2DM IN CHINA

    May 1, 2016, 00:00
  • Table of Contents

    May 1, 2016, 00:00
  • Cost of Illness Analysis of Nocturia in Germany, Sweden, and the United Kingdom

    May 1, 2016, 00:00
  • COST-EFFECTIVENESS ANALYSIS OF DULAGLUTIDE COMPARED WITH INSULIN GLARGINE ADD ON TO INSULIN LISPRO IN TREATMENT OF TYPE 2 DIABETES- A US THIRD-PARTY PAYER PERSPECTIVE

    May 1, 2016, 00:00
  • ASSESSMENT OF GASTROINTESTINAL RISK LEVEL USING STANDARDIZED CALCULATOR OF RISK FOR EVENTS AND TREATMENT PATTERNS OF ARTHRITIS PATIENTS IN REAL CLINICAL SETTINGS IN KOREA

    May 1, 2016, 00:00
  • Model Observational Bridging Study on the Effectiveness of Ezetimibe on Cardiovascular Outcomes

    May 1, 2016, 00:00
  • Factors Affecting Participation In Breast Cancer Screening

    May 1, 2016, 00:00
  • Cost Analysis Of Patients With Multiple Sclerosis Newly Initiating Subcutaneous Interferon β-1a Versus Oral Disease-Modifying Drugs

    May 1, 2016, 00:00
  • Achieving Faster Product Launch- How Do You Obtain Non-Reimbursed Pharmaceutical Prices Across Europe?

    May 1, 2016, 00:00
  • A Study To Determine The Economic Impact Of Major Depressive Disorder In Colombia

    May 1, 2016, 00:00
  • COST EFFECTIVENESS OF CRYOABLATION VERSUS CONVENTIONAL RADIOFRECUENCY PULMONARY VEIN ISOLATION FOR THE TREATMENT OF PATIENTS WITH PAROXISMAL ATRIAL FIBRILATION IN COLOMBIA

    May 1, 2016, 00:00
  • DEVELOPING GUIDELINES FOR MIGRATING THE ACTS, A PAPER PRO, TO WEB FORMAT

    May 1, 2016, 00:00
  • Rates of Subsequent Endometriosis-Related Surgeries Following an Initial Laparoscopy Or Hysterectomy- A Longitudinal Analysis of Commercially Insured Endometriosis Patient in The United States

    May 1, 2016, 00:00
  • IMPROVING THE CLINICAL PRACTICE GUIDELINES- WHY INCLUDE PSYCHOLOGICAL EVALUATION AND INTERVENTION?

    May 1, 2016, 00:00
  • Use of Real-World Data to Estimate Prevalence of Commercially-Insured High Cardiovascular Risk Patients in the United States

    May 1, 2016, 00:00
  • Health Care Inequality And Business Cycles In Japan

    May 1, 2016, 00:00
  • Predictors of Publication For Biomedical Research

    May 1, 2016, 00:00
  • Indirect Treatment Comparison Of Cabazitaxel For Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Been Previously Treated With A Docetaxel-Containing Regimen

    May 1, 2016, 00:00
  • Post-Mastectomy Breast Reconstruction and its Subsequent Complications- A Comparison between Obese and Non-Obese Women With Breast Cancer

    May 1, 2016, 00:00
  • Unlocking Smartphone Potential in Health Care by Providing Smartphones to Patients- A Systematic Review

    May 1, 2016, 00:00
  • A UK ANALYSIS OF THE DIFFERENTIAL DRUG COSTS PER 1% POINT DECREASE IN HBA1C AMONG ANTIHYPERGLYCEMIC AGENTS THAT INHIBIT SGLT2

    May 1, 2016, 00:00
  • Examining Length of Stay and Home Discharge when Using Bupivacaine Liposomal Injectable Suspension in Medicare Patients Undergoing Total Hip Arthroplasty

    May 1, 2016, 00:00
  • PATIENT-REPORTED OUTCOMES AMONG TREATED RHEUMATOID ARTHRITIS PATIENTS

    May 1, 2016, 00:00
  • CLINICAL AND ECONOMIC OUTCOMES OF FIBRIN SEALANTS (EVICEL AND TISSEEL) USED FOR HEMOSTASIS IN CORONARY ARTERY BYPASS GRAFTING SURGERY IN THE UNITED STATES

    May 1, 2016, 00:00
  • Managed Entry Agreements For Pharmaceutical Products In Mena Countries- Payer And Manufacturer Experience And Outlook

    May 1, 2016, 00:00
  • The Concentration of Health Care Expenditure of a Colombian Public Health Insurance Company

    May 1, 2016, 00:00
  • BUDGET IMPACT ANALYSIS FOR THE FIRST-LINE AND SECOND-LINE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

    May 1, 2016, 00:00
  • Patient Preference for Display of Electronic Patient-Reported Outcomes- Wording Emphasis, Question Format, and Navigation Button Placement

    May 1, 2016, 00:00
  • Is Obinituzumab the most Cost-Effective Biological Therapy for Unfit Patients with Previously Untreated Chronic Lymphocytic Leukemia in Colombia?

    May 1, 2016, 00:00
  • Long-Term Cost Effectiveness Analysis Of Ideglira Versus Glp-1 Added To Basal Insulin As Intensification Therapies In Type 2 Diabetes Mellitus In Spain

    May 1, 2016, 00:00
  • Variation in Medication Adherence across the Health Care System in Comparative-Effectiveness Research Studies

    May 1, 2016, 00:00
  • Knowledge and Practices Related to Rational Use of Antibiotics in Panama

    May 1, 2016, 00:00
  • DEVELOPMENT AND EVALUATION OF ADVERSE DRUG REACTION RISK-SCORE FOR IN-HOSPITAL PATIENTS

    May 1, 2016, 00:00
  • Caregiver Burden In The United States Workfor Health Care Resource Utilization And Quality of Life

    May 1, 2016, 00:00
  • COST EFFECTIVENESS OF ALLOGENIC PANCREATIC ISLET TRANSPLANTATION VERSUS WHOLE PANCREAS TRANSPLANTATION IN THE UNITED KINGDOM

    May 1, 2016, 00:00
  • ESTIMATION OF HEALTH BENEFITS FROM SUCCESSFUL PREVENTION OF AN ILLNESS- METHODS AND EXAMPLES

    May 1, 2016, 00:00
  • Antihypertensive and Antilipemic Medication use and Emergency Room Expenditures Among Adults with Coexisting Hypertension and Hyperlipidemia

    May 1, 2016, 00:00
  • COST-EFFECTIVENESS OF ATAZANAVIR/RITONAVIR AGAINST LOPINAVIR/RITONAVIR IN THE TREATMENT OF PEOPLE LIVING WITH HIV IN PERU

    May 1, 2016, 00:00
  • PREVALENCE AND OUTCOMES OF FEAR OF NEEDLES AND ASSOCIATED PSYCHOLOGICAL CONDITIONS AMONG PATIENTS MANAGING DIABETES

    May 1, 2016, 00:00
  • ANALYSIS OF TRENDS IN UTILIZATION AND COST OF INSULIN IN THE UNITED STATES AND CANADA

    May 1, 2016, 00:00
  • Colorectal Cancer Patient Satisfaction with the Multidisciplinary Treatment in a High Specialty Unit at Instituto Mexicano Del Seguro Social

    May 1, 2016, 00:00
  • ESTIMATING HOSPITAL COSTS FOR MEDICARE PATIENTS UNDERGOING TOTAL KNEE ARTHROPLASTY USING PREMIER CHARGEMASTER DATA

    May 1, 2016, 00:00
  • Explaining the Variation in Oncology Medication Spending Across Selected Oecd Countries

    May 1, 2016, 00:00
  • DEVELOPMENT OF THE IMPACT OF OPIOID ON BIOPYSCHOSOCIAL-SPIRITUAL FUNCTIONS (IOBPSS) SCALE IN ACUTE AND CHRONIC PAIN

    May 1, 2016, 00:00
  • PHRMACEUTICAL DEVELOPMENT- AFRICA AN EMERGENT MARKET

    May 1, 2016, 00:00
  • Types of Chronic Conditions Combinations and Initial Cancer Treatment among Elderly Medicare Beneficiaries with Localized Prostate Cancer

    May 1, 2016, 00:00
  • HOW VALUABLE IS A CANCER THERAPY? IT DEPENDS ON WHOM YOU ASK

    May 1, 2016, 00:00
  • ECONOMIC EVALUATION OF ERTAPENEM IN THE TREATMENT OF SEPSIS FROM ENTEROBACTERIA PRODUCING BETA-LACTAMASES OF EXTENDED SPECTRUM (BLEES) AT THE MEXICO CHILDREN’S HOSPITAL “FEDERICO GOMEZ”

    May 1, 2016, 00:00
  • European HTA, Pricing And Reimbursement Roadmaps- Revisited 2016

    May 1, 2016, 00:00
  • Retrospective Chart Review Study to Evaluate Health Care Resource Utilization in Patients with Symptomatic Multiple Myeloma in Italy

    May 1, 2016, 00:00
  • Economic Analysis of Drug-Coated Balloons And Other Endovascular Treatments For Femoropopliteal Artery Disease In The United Kingdom

    May 1, 2016, 00:00
  • Evaluation of Asthma Outcomes in Older and Younger Adults

    May 1, 2016, 00:00
  • Combination Therapy Of Braf Inhibitors For Advanced Melanoma With V600 Braf Mutation- A Systematic Review And Meta-Analysis

    May 1, 2016, 00:00
  • THE REAL-WORLD PAIN EXPERIENCE OF ADULTS WITH RHEUMATOID ARTHRITIS USING A MOBILE SURVEY

    May 1, 2016, 00:00
  • Characterization of Statin Effectiveness using Real-World Data in a Canadian Population

    May 1, 2016, 00:00
  • The Role of Patient-Reported Outcomes in Drug-Coverage Decisions for New Agents with Advanced Melanoma Indication

    May 1, 2016, 00:00
  • Death Burden Of Pneumococcal Disease On Brazilian Private Health System

    May 1, 2016, 00:00
  • DIRECT OUT OF POCKET EXPENDITURE FOR MEDICAL CARE OF TYPE 1 DIABETIC PATIENTS ATTENDING A TERTIARY CARE HOSPITAL

    May 1, 2016, 00:00
  • Factors Influencing The Participation Rate On Organized Breast Bancer Screening Programme In Hungary

    May 1, 2016, 00:00
  • Impact of Dry Eye Disease on Quality of Life, Work Productivity, Daily Activities, and Health Care Resource Use in a Survey of 74,095 American Adults

    May 1, 2016, 00:00
  • INSIGHTS FOR CARE- USING REAL-WORLD DATA TO QUANTIFY DIABETES TREATMENT PATTERNS AND OUTCOMES IN AN URBAN HEALTH ECONOMY

    May 1, 2016, 00:00
  • CHARACTERIZATION OF MALE AND FEMALE USERS OF TESTOSTERONE AMONG THE COMMERCIALLY INSURED POPULATION IN THE UNITED STATES

    May 1, 2016, 00:00
  • Current Situation and Prospect of Pediatric Medicine in China

    May 1, 2016, 00:00
  • Natural Language Processing-Identified Problem Opioid Use And Its Associated Health Care Costs

    May 1, 2016, 00:00
  • BETTER EFFECTIVENESS OF HERPES ZOSTER VACCINE IN PREVENTING HERPES ZOSTER OPHTHALMICUS WITH OCULAR INVOLVEMENT

    May 1, 2016, 00:00
  • Examining Health-Related Productivity Losses due To Uterine Fibroids in the United States Using the Health-Related Productivity Questionnaire

    May 1, 2016, 00:00
  • Do formulary drug exclusion policies always save money? A literature review

    May 1, 2016, 00:00
  • Checklist To Assess The Feasibility Of A Network Meta-Analysis

    May 1, 2016, 00:00
  • Factors Influencing Resection in Locoregional Pancreatic Cancer Patients

    May 1, 2016, 00:00
  • Depression Treatment and Health-Related Quality of Life Among Adults with Arthritis and Depression in the United States

    May 1, 2016, 00:00
  • USING READILY AVAILABLE ADMINISTRATIVE DATA ELEMENTS TO PREDICT FUTURE MEDICATION NON-ADHERENCE AMONG COPD PATIENTS WITH EMPLOYER-SPONSORED INSURANCE

    May 1, 2016, 00:00
  • Dealing With Uncertainty And Accounting For Social Value Judgments In Value Assessments For Orphan Drugs- Qualitative Evidence From Four European Countries

    May 1, 2016, 00:00
  • Systematic Review of Clinical and Economic Outcomes Related to Surgical Site Infections in Latin America

    May 1, 2016, 00:00
  • Profiles of Performance of Health Service Providers to Implement a Pay-For-Performance Mechanism- Simulation Approach

    May 1, 2016, 00:00
  • Development and Validation of Patient Decision Aid for Antidepressant Medications

    May 1, 2016, 00:00
  • Value of Innovation in Oncology Treatments for Patients in Sweden with Advanced or Metastatic Non-Small Cell Lung Cancer

    May 1, 2016, 00:00
  • A Review Evaluating the Validity of Smartphone Sensors and Components to Measure Clinical Outcomes in Clinical Research

    May 1, 2016, 00:00
  • Validation of A Cost-Effectiveness Model Comparing Accuracy of Genetic Tests For Brca Mutations

    May 1, 2016, 00:00
  • Current Literature Describing the Clinical Utility and Economic Value of Cancer Molecular Diagnostics

    May 1, 2016, 00:00
  • Examining the Value of Menopausal Symptom Relief Among US Women

    Mar 1, 2016, 00:00
  • Methods Used in Economic Evaluations of Tuberculin Skin Tests and Interferon Gamma Release Assays for the Screening of Latent Tuberculosis Infection- A Systematic Review

    Mar 1, 2016, 00:00
  • Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices- Report 2 of the ISPOR MCDA Emerging Good Practices Task Force

    Mar 1, 2016, 00:00
  • Patient-Centered Outcomes of Medication Adherence Interventions- Systematic Review and Meta-Analysis

    Mar 1, 2016, 00:00
  • Challenges in Using MCDA for Reimbursement Decisions on New Medicines?

    Mar 1, 2016, 00:00
  • Estimating the Cost-Effectiveness of Implementation- Is Sufficient Evidence Available?

    Mar 1, 2016, 00:00
  • The Cost-Effectiveness of Prostate Cancer Detection with the Use of Prostate Health Index

    Mar 1, 2016, 00:00
  • Instructions for Authors

    Mar 1, 2016, 00:00
  • Copyright/Subscription

    Mar 1, 2016, 00:00
  • Systematic Review of Economic Evaluations of Units Dedicated to Acute Coronary Syndromes

    Mar 1, 2016, 00:00
  • The Use of Economic Evidence to Inform Drug Pricing Decisions in Jordan

    Mar 1, 2016, 00:00
  • Sources and Characteristics of Utility Weights for Economic Evaluation of Pediatric Vaccines- A Systematic Review

    Mar 1, 2016, 00:00
  • Responsiveness to Change in PROMIS Pediatric Asthma Study

    Mar 1, 2016, 00:00
  • Improving Adherence to Cardiovascular Therapies- An Economic Evaluation of a Randomized Pragmatic Trial

    Mar 1, 2016, 00:00
  • Cost-Effectiveness of Incobotulinumtoxin-A with Flexible Treatment Intervals Compared to Onabotulinumtoxin-A in the Management of Blepharospasm and Cervical Dystonia

    Mar 1, 2016, 00:00
  • Preferences for Prostate Cancer Outcomes- A Comparison of the Patient Perspective, the General Population Perspective, and a Population at Risk for Prostate Cancer

    Mar 1, 2016, 00:00
  • Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods- Does Dimension Order Impact on Health State Values?

    Mar 1, 2016, 00:00
  • Comprehensively Measuring Health-Related Subjective Well-Being- Dimensionality Analysis for Improved Outcome Assessment in Health Economics

    Mar 1, 2016, 00:00
  • Erratum

    Mar 1, 2016, 00:00
  • Valuing Treatments for Parkinson Disease Incorporating Process Utility- Performance of Best-Worst Scaling, Time Trade-Off, and Visual Analogue Scales

    Mar 1, 2016, 00:00
  • Expanding Health Technology Assessments to Include Effects on the Environment

    Mar 1, 2016, 00:00
  • Cost-Effectiveness of a Collaborative Care Depression and Anxiety Treatment Program in Patients with Acute Cardiac Illness

    Mar 1, 2016, 00:00
  • Table of Contents

    Mar 1, 2016, 00:00
  • Survival or Mortality- Does Risk Attribute Framing Influence Decision-Making Behavior in a Discrete Choice Experiment?

    Mar 1, 2016, 00:00
  • Evaluation of Resource Utilization and Treatment Patterns in Patients with Actinic Keratosis in the United States

    Mar 1, 2016, 00:00
  • A Simple and Practical Index to Measure Dementia-Related Quality of Life

    Jan 1, 2016, 00:00
  • Copyright/Subscription

    Jan 1, 2016, 00:00
  • Impact of the 12-Gene Colon Cancer Assay on Clinical Decision Making for Adjuvant Therapy in Stage II Colon Cancer Patients

    Jan 1, 2016, 00:00
  • The Parity Paradigm- Can Legislation Help Reduce the Cost Burden of Oral Anticancer Medications?

    Jan 1, 2016, 00:00
  • Assessing Patient-Reported Outcomes in Pediatric Populations With Vaccine-Preventable Infectious Diseases- A Systematic Review of the Literature (the PROCHID Study)

    Jan 1, 2016, 00:00
  • Thirty Years of Media Coverage on High Drug Prices in the United States—A Never-Ending Story or a Time for Change?

    Jan 1, 2016, 00:00
  • Table of Contents

    Jan 1, 2016, 00:00
  • Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction- Report 1 of the ISPOR MCDA Emerging Good Practices Task Force

    Jan 1, 2016, 00:00
  • The Reporting of Treatment Nonadherence and Its Associated Impact on Economic Evaluations Conducted Alongside Randomized Trials- A Systematic Review

    Jan 1, 2016, 00:00
  • Do You Want to Hear the Bad News? The Value of Diagnostic Tests for Alzheimer’s Disease

    Jan 1, 2016, 00:00
  • New French Coverage with Evidence Development for Innovative Medical Devices- Improvements and Unresolved Issues

    Jan 1, 2016, 00:00
  • Instructions for Authors

    Jan 1, 2016, 00:00
  • Changes in Quality of Life Associated with Complications of Diabetes- Results from the ADVANCE Study

    Jan 1, 2016, 00:00
  • Cost-Effectiveness of Integrating a Clinical Decision Rule and Staged Imaging Protocol for Diagnosis of Appendicitis

    Jan 1, 2016, 00:00
  • Errata

    Jan 1, 2016, 00:00
  • The “Efficacy-Effectiveness Gap”- Historical Background and Current Conceptualization

    Jan 1, 2016, 00:00
  • The Cost of Increasing Physical Activity and Maintaining Weight for Midlife Sedentary African American Women

    Jan 1, 2016, 00:00
  • Concept Elicitation Within Patient-Powered Research Networks- A Feasibility Study in Chronic Lymphocytic Leukemia

    Jan 1, 2016, 00:00
  • An Empirical Study of Two Alternative Comparators for Use in Time Trade-Off Studies

    Jan 1, 2016, 00:00
  • Health-Related Quality of Life and Health Utilities in Metastatic Castrate-Resistant Prostate Cancer- A Survey Capturing Experiences from a Diverse Sample of UK Patients

    Dec 1, 2015, 00:00
  • Table of Contents

    Dec 1, 2015, 00:00
  • Using Decision-Analytic Modeling to Isolate Interventions That Are Feasible, Efficient and Optimal- An Application from the Norwegian Cervical Cancer Screening Program

    Dec 1, 2015, 00:00
  • Long-Term Efficacy of Etanercept for Plaque-Type Psoriasis and Estimated Cost in Daily Clinical Practice

    Dec 1, 2015, 00:00
  • Beware of Kinked Frontiers- A Systematic Review of the Choice of Comparator Strategies in Cost-Effectiveness Analyses of Human Papillomavirus Testing in Cervical Screening

    Dec 1, 2015, 00:00
  • Time Series Analysis on the Impact of Generic Substitution and Reference Pricing on Antipsychotic Costs in Finland

    Dec 1, 2015, 00:00
  • A Quality-Adjusted Life-Year Measure for Multiple Sclerosis- Developing a Patient-Reported Health State Classification System for a Multiple Sclerosis-Specific Preference-Based Measure

    Dec 1, 2015, 00:00
  • Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology- The BEST II Study

    Dec 1, 2015, 00:00
  • Development of the Treatment Inventory of Costs in Psychiatric Patients- TIC-P Mini and Midi

    Dec 1, 2015, 00:00
  • Economic Evaluation of Cinacalcet in the United States- The EVOLVE Trial

    Dec 1, 2015, 00:00
  • Health Utility Values Associated with Surgical Site Infection- A Systematic Review

    Dec 1, 2015, 00:00
  • A Vision “Bolt-On” Item Could Increase the Discriminatory Power of the EQ-5D Index Score

    Dec 1, 2015, 00:00
  • Reliability and Validity of the Work Instability Scale for Rheumatoid Arthritis

    Dec 1, 2015, 00:00
  • Cost-Effectiveness of Chemotherapy for Breast Cancer and Age Effect in Older Women

    Dec 1, 2015, 00:00
  • Copyright/Subscription

    Dec 1, 2015, 00:00
  • HIV Treatment in Resource-Limited Environments- Treatment Coverage and Insights

    Dec 1, 2015, 00:00
  • Erratum

    Dec 1, 2015, 00:00
  • Comparison of Benefit-Risk Assessment Methods for Prospective Monitoring of Newly Marketed Drugs- A Simulation Study

    Dec 1, 2015, 00:00
  • Appropriateness of Prescriptions of Recommended Treatments in Organisation for Economic Co-operation and Development Health Systems- Findings Based on the Long-Term Registry of the European Society of Cardiology on Heart Failure

    Dec 1, 2015, 00:00
  • HIQA’s CEA of Breast Screening- Pragmatic Policy Recommendations are Welcome, but ACERs Reported as ICERs are Not

    Dec 1, 2015, 00:00
  • Quality of Life and Asthma Symptom Control- Room for Improvement in Care and Measurement

    Dec 1, 2015, 00:00
  • Prospective Benefit-Risk Monitoring of New Drugs for Rapid Assessment of Net Favorability in Electronic Health Care Data

    Dec 1, 2015, 00:00
  • Estimating a Preference-Based Index for an Eight-Dimensional Health State Classification System for Multiple Sclerosis

    Dec 1, 2015, 00:00
  • Citizens’ Perspectives on Disinvestment from Publicly Funded Pathology Tests- A Deliberative Forum

    Dec 1, 2015, 00:00
  • The Suitability of End Point Designs for Health Technology Assessment in Chronic Pain Studies

    Dec 1, 2015, 00:00
  • Cost-Effectiveness of Disease Management Programs for Cardiovascular Risk and COPD in The Netherlands

    Dec 1, 2015, 00:00
  • Instructions for Authors

    Dec 1, 2015, 00:00
  • Impact and Cost-Effectiveness of Hypothetical Strategies to Enhance Retention in Care within HIV Treatment Programs in East Africa

    Dec 1, 2015, 00:00
  • Using Generalized Linear Mixed Models to Evaluate Inconsistency within a Network Meta-Analysis

    Dec 1, 2015, 00:00
  • The Burden of Diabetes Mellitus in Patients with Coronary Heart Disease- A Methodological Approach to Assess Quality-Adjusted Life-Years Based on Individual-Level Longitudinal Survey Data

    Dec 1, 2015, 00:00
  • Development and Content Validity Testing of a Patient-Reported Treatment Acceptance Measure for Use in Patients Receiving Treatment via Subcutaneous Injection

    Dec 1, 2015, 00:00
  • The Use of Real World Evidence to Influence Practi A Systematic Review of Cprd Studies In English Guidances And Guidelines

    Nov 1, 2015, 00:00
  • Relationship Between The Provision of Injection Services In Ambulatory Physician Offices And Prescribing Injectable Medicines In Iran

    Nov 1, 2015, 00:00
  • Social Burden of Chronic Hcv Infection in Patients with Hepatocellular Carcinoma

    Nov 1, 2015, 00:00
  • Torsade De Pointes And Qt Prolongation Could Result From Desloratadine Anti-Allergy Treatment

    Nov 1, 2015, 00:00
  • Economic Evaluation of Second Line Oral Antidiabetics for Type 2 Diabetes in Colombia

    Nov 1, 2015, 00:00
  • Virtual Consultation System To Enable Rare Diseases Diagnosis

    Nov 1, 2015, 00:00
  • Healthcare Burden and Economic Cost of Hospitalisation During Chemotherapy for Adult Patients with Ph-Negative B-Precursor Relapsed or Refractory (R/R) Acute Lymphoblastic Leukaemia (All) in France

    Nov 1, 2015, 00:00
  • Hospitalization Cost and Length of Stay Associated with Ophthalmological Surgery Depending on the Diabetic Status

    Nov 1, 2015, 00:00
  • Assessment of Compliance among Patients with Arthritis

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis Of Bemiparin Used As Acute Treatment For Deep Venous Thrombosis Without Pulmonary Embolism

    Nov 1, 2015, 00:00
  • Market Access of Atmps- Overview and Expected Challenges

    Nov 1, 2015, 00:00
  • Factors Associated With The Duration Of Anticoagulation Therapy Following Acute Vte In England In General Practi An Observational Study Using Cprd-Hes Databases

    Nov 1, 2015, 00:00
  • The Efficiency Path- An Estimation of Cost-Effectiveness Thresholds for 185 Countries Based on Per Capita Health Expenditures and Life Expectancy

    Nov 1, 2015, 00:00
  • Defining Market Access in Brazil- the Pharma Professionals’ Perspective

    Nov 1, 2015, 00:00
  • Economic Aspects in the Management of Diabetes in Italy

    Nov 1, 2015, 00:00
  • Assessment of The Association Between Sleep Behaviors and Experiential Outcomes Among A Multinational Adult Population

    Nov 1, 2015, 00:00
  • Current Clinical Practice Correspondence With Treatment Guidelines In Patients With Type 2 Diabetes Mellitus

    Nov 1, 2015, 00:00
  • Economic and Clinical Impact of Secondhand Smoking In Korea

    Nov 1, 2015, 00:00
  • Psychiatric Healthcare Utilization and Related Costs In Newly Diagnosed Individuals With Autism Spectrum Disorder (Asd) In Quebec (Canada)

    Nov 1, 2015, 00:00
  • Current Treatment Patterns In Patients With Metastatic Melanoma- A Retrospective Claims Database Analysis In The United States (Us)

    Nov 1, 2015, 00:00
  • A Study of Knowledge, Attitude And Practice of Community Pharmacists Towards Adverse Drug Reaction Reporting Monitoring

    Nov 1, 2015, 00:00
  • Disease Progression In Rheumatoid Arthritis- Key Element for Cost-Effectiveness Modelling

    Nov 1, 2015, 00:00
  • Influence Of The Method Of Analysis On Estimates Of Qaly Treatment Differen Phase Iii Trial Of Vinflunine Versus Best Supportive Care In Patients With Tccu

    Nov 1, 2015, 00:00
  • Predictors Of Utility Over Time Among Patients With Treatment-Naïve Advanced Melanoma From The Phase 3 Checkmate 066 Trial

    Nov 1, 2015, 00:00
  • TRANSLATION AND LINGUISTIC VALIDATION OF THE MODIFIED MYELOPROLIFERATIVE NEOPLASM SYMPTOM ASSESSMENT FORM - TOTAL SYMPTOM SCORE (MMPN-SAF TSS) FOR USE IN 26 COUNTRIES

    Nov 1, 2015, 00:00
  • Association of Treatment with Carvedilol, Bisoprolol and Metoprolol on the Risk of Mortality and Hospital Admission Among Older Adults with Heart Failure

    Nov 1, 2015, 00:00
  • Economic Impact of A Volumetric Infusion Pump (Infusomat® Space) + Central Alarm Management (One View), In The Risk Prevention In Infusion Therapy In The Intensive Care Unit (Icu) In Mexico

    Nov 1, 2015, 00:00
  • Acessibilidade De Obesos M”Rbidos Usuários Do Sistema Público De Saúde No Brasil

    Nov 1, 2015, 00:00
  • Liste-En-Sus Reform In France - What are The Consequences?

    Nov 1, 2015, 00:00
  • Estimating The Public Health Impact Of A Vaccination Programme With A Nonavalent Hpv Vaccine In Germany

    Nov 1, 2015, 00:00
  • Transparency and Reproducibility of Supplementary Search Methods in Nice Single Technology Appraisal Manufacturer Submissions

    Nov 1, 2015, 00:00
  • Assessing the Public Health Impact and Cost Effectiveness of Pneumococcal Vaccines for Adults 65 Years of Age in Colombia

    Nov 1, 2015, 00:00
  • Evalución Económica Completa Del Sistema De Terapia De Radiación Con Rayos X Para El Tratamiento Cáncer De Próstata De Alto Riesgo En México

    Nov 1, 2015, 00:00
  • The Cost-Effectiveness (CE) of Intravitreal Aflibercept (IVT-AFL) in the Treatment of Diabetic Macular Edema (DME) in Turkey

    Nov 1, 2015, 00:00
  • Recent Hypoglycemia Episodes Are Associated With Poorer Quality Of Life, Healthcare Resource Use, And Work Impairment Among Patients With Type II Diabetes In Brazil

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Of A 13-Valent Conjugate Pneumococcal Vaccination Program In Copd Patients Aged 50+ Years In Spain

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Certolizumab Pegol for The Treatment of Axial Spondyloarthritis In Turkey

    Nov 1, 2015, 00:00
  • Caracterización de Pacientes Con Múltiples Enfermedades Crónicas desde la Perspectiva Del Aseguramiento en Colombia

    Nov 1, 2015, 00:00
  • Burden of Disease of Diabetes Mellitus Typ-2 In Austria

    Nov 1, 2015, 00:00
  • Assessment Of Knowledge And Awareness Regarding Asthma Among School Teachers In Quetta

    Nov 1, 2015, 00:00
  • Examining Health System And Resource Utilization And Medical Management Of Patients Idiopathic Pulmonary Fibrosis In Ontario- A Preliminary Analysis

    Nov 1, 2015, 00:00
  • Budget Impact Analysis of The Use of Alteplase In The Treatment of Acute Ischaemic Stroke In Mexico

    Nov 1, 2015, 00:00
  • Evaluacion Sobre Medicamentos y Actos Medicos Cubiertos Financieramente Por Resolucion Judicial- Fnr

    Nov 1, 2015, 00:00
  • Modelling Methods for Eq-5d – a Fitting Time for Change

    Nov 1, 2015, 00:00
  • Mapping the Beck Depression Inventory to the Eq-5d-3l in Patients with Depressive Disorders

    Nov 1, 2015, 00:00
  • Prevention and Treatment of Missing Data in Real World Research

    Nov 1, 2015, 00:00
  • The Cost of Non-Severe Hypoglycaemia In Europe

    Nov 1, 2015, 00:00
  • Apheresis Treatment In German Patients With Severe Hypercholesterolemia - A Psychodrama Market Research

    Nov 1, 2015, 00:00
  • What is the Most Cost-Effective way to Set-Up Organised Cervical Cancer Screening in France? a Budget Impact Analysis

    Nov 1, 2015, 00:00
  • Development Of A Model To Provide Insight In The Value Of Fibrinogen Concentrate For Treating Excessive Bleedings During Complex Cardiovascular Surgery

    Nov 1, 2015, 00:00
  • Direct Evidence Versus Lack of Direct Evidence and the Impact on HTA Acceptance

    Nov 1, 2015, 00:00
  • Qualitative Discussion on Issues of Patient-Reported Outcome Assessment in Post-Marketing Surveillance for Diseases in the Elderly

    Nov 1, 2015, 00:00
  • Bayesian Network Meta-Analysis To Assess The Comparative Efficacy And Safety Of Treatments For Severe Or Uncontrolled Asthma

    Nov 1, 2015, 00:00
  • Utilização Do Escore De Propensão Na Comparação De Duas Opç’es Terapêuticas Em Pacientes Com Carcinoma Epiderm”Ide De Cabeça E Pescoço, Brasil 1998-2008

    Nov 1, 2015, 00:00
  • Potential Economic Impact Of Inhalation Errors Due To Device Switch In Patients With Chronic Obstructive Pulmonary Disease And Asthma

    Nov 1, 2015, 00:00
  • The Health And Medical Care Costs For Hospitalized All-Cause Pneumonia Among Children 2 Years, Pre And Postthe Introduction Of Prevenar13 In Sweden

    Nov 1, 2015, 00:00
  • Costo De Cáncer De Colon Avanzado En Los Establecimientos Hospitalarios Del Perú

    Nov 1, 2015, 00:00
  • Matching-Adjusted Indirect Treatment Comparison And Survival Extrapolation In Radioiodine-Refractory Differentiated Thyroid Cancer (Rai-Refractory Dtc)- Updated Analysis

    Nov 1, 2015, 00:00
  • Hospitalisations Among Adult Patients with Ph-Negative B-Precursor Relapsed or Refractory (R/R) Acute Lymphoblastic Leukaemia (All) Receiving Chemotherapy in Germany- A Retrospective Chart Review

    Nov 1, 2015, 00:00
  • The Use Comparative Effectiveness Research And Evidence Based Medicine In Us Payor Decision Making

    Nov 1, 2015, 00:00
  • The Use of Indirect Comparisons in Medicines Evaluation for their Access To Reimbursement by the Has

    Nov 1, 2015, 00:00
  • The Epidemiological and Cost Burden of Herpes Zoster (Hz) and Post-Herpetic Neuralgia (Phn) in the Uk

    Nov 1, 2015, 00:00
  • Predictors of Positive Decision Outcomes by the Cancer Drugs Fund

    Nov 1, 2015, 00:00
  • Public Health Impact and cost-Effectiveness of Malaria routine Vaccination in Infants

    Nov 1, 2015, 00:00
  • Epidemiology and Current Treatment of Neuromyelitis Optica- A Systematic Review

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Esomeprazole Compared With Other Ppis Currently Reimbursed In Poland In The Treatment of Gerd

    Nov 1, 2015, 00:00
  • Validation of A Markov Model for Economic Evaluation of Screening and Preventive Interventions In Alzheimer’s Disease In Denmark

    Nov 1, 2015, 00:00
  • The Use Of Real World Evidence (Rwe) To Investigate The Overall Treatment Effects Of Different Lines Of Therapy In Rheumatoid Arthritis

    Nov 1, 2015, 00:00
  • Cost And Resource Utilization Of Uncontrolled And Persistent Asthma In Canada- A Systematic Literature Review

    Nov 1, 2015, 00:00
  • Challenges to The Economic Modelling of Macular Oedema Due to Retinal Vein Occlusion And Diabetes

    Nov 1, 2015, 00:00
  • Economic Evaluation of The Aranesp Application for Anemia Correction In Pathients With Chronical Renal Failure on Hemodialysis or Peritoneal Dialysis In Russia

    Nov 1, 2015, 00:00
  • The Uk Pharmaceutical Price Regulation Scheme (Pprs) – Considerations of Voluntary Versus Statutory Regulations and How to Negotiate Pricing

    Nov 1, 2015, 00:00
  • Overview of Nub Process for In-Patient Drugs and Devices In German

    Nov 1, 2015, 00:00
  • Ranking of Disease-Modifying Therapies for Multiple Sclerosis

    Nov 1, 2015, 00:00
  • Applied Comparison of Meta-Analysis Techniques

    Nov 1, 2015, 00:00
  • Out Hospital Drug Consumption in Therapy of Obstructive Pulmonary Disease in Serbia in the Period from 2007 to 2012

    Nov 1, 2015, 00:00
  • Health-Related Quality Of Life (Hrqol) Benefits Of Enzalutamide In Patients With Metastatic Castration-Resistant Prostate Cancer (Mcrpc)- An In-Depth Analysis Of Eq-5d Data From The Prevail Trial

    Nov 1, 2015, 00:00
  • Assessment of Effective Incentives for Blood Donations. How can citizens be Motivated to donate Blood?

    Nov 1, 2015, 00:00
  • The Expansion of Use of Discounted Prices for International Reference Pricing Purposes

    Nov 1, 2015, 00:00
  • New Nhi Reimbursement Coverage Paradigm Called ‘Selective Reimbursement Scheme’ On The Four Major Diseases In Korea

    Nov 1, 2015, 00:00
  • Health-Related Quality Of Life (Hrqol) Measures In Autosomal Dominant Polycystic Kidney Disease (Adpkd)

    Nov 1, 2015, 00:00
  • Evaluation of Who/Inrud Prescribing Indicators and Prescribing Trend of Antibiotics in Accidents and Emergency Department, Bahawal Victoria Hospital, Bahawalpur, Pakistan

    Nov 1, 2015, 00:00
  • Economic Assessment of Eltrombopag In The Treatment of Thrombocytopenia In Italy

    Nov 1, 2015, 00:00
  • Relationship between Pain, Functional Disability and Health-Related Quality of Life in Patient with Failed Back Surgery Syndrome Undergoing Spinal Cord Stimulation- Results from the Precise Study

    Nov 1, 2015, 00:00
  • Economic Evaluation of Infliximab for Treatment of Refractory Ulcerative Colitis In Iran- Cost-Effectiveness Analysis

    Nov 1, 2015, 00:00
  • ‘How Does that Make You feel?’ - the Ambiguity of Translating Depression

    Nov 1, 2015, 00:00
  • Cost-Minimization For A Novel Ibs Diagnostic Blood Panel Versus Standard Exclusionary Diagnostic Testing For Diarrhea Predominant Irritable Bowel Syndrome- A United States Perspective

    Nov 1, 2015, 00:00
  • The Relative Efficacy And Safety Of Treatments In Second-Line Management Of Chronic Myeloid Leukaemia- Systematic Review And Network Meta-Analysis Feasibility Study

    Nov 1, 2015, 00:00
  • Estimacion Del Costo De Tratamiento De Un Evento Moderado Versus Uno Severo De Hipoglucemia En Pacientes Con Diabetes Mellitus Tipo 2 En Mexico Desde La Opinion De Expertos

    Nov 1, 2015, 00:00
  • A New Cost-Effectiveness Modelling Approach In Chronic Heart Failure With Reduced Ejection Fraction

    Nov 1, 2015, 00:00
  • Anaesthesia In Developing Countries

    Nov 1, 2015, 00:00
  • Epidemiology of Statin-Treated Patients with Uncontrolled Ldl Levels from Italian Administrative Official Databases

    Nov 1, 2015, 00:00
  • Impact of Healthcare Reforms on Pricing and Reimbursement In Turkey

    Nov 1, 2015, 00:00
  • Budgetary Implications Of Introducing The Gsk Ellipta Portfolio For Copd In The Uk

    Nov 1, 2015, 00:00
  • Development and Validation of a Questionnaire Assessing the fears and Beliefs of Patients Suffering from Chronic Rheumatic Diseases

    Nov 1, 2015, 00:00
  • Systematic Review of Esomeprazole for The Treatment of Gastroesophageal Reflux Disease

    Nov 1, 2015, 00:00
  • Causas Y Factores Asociados Al Delirium En Pacientes Mayores De 65 Años Que Solicitan Atención Médica De Urgencias

    Nov 1, 2015, 00:00
  • Preliminary Study of Safety and Efficacy of Warfarin Versus Dabigatran in Atrial Fibrillation Patients in a Tertiary Hospital in Malaysia

    Nov 1, 2015, 00:00
  • Comparison Of Kras Tested And Not-Tested Metastatic Colorectal Cancer (Mcrc) Patient Cohorts In Europe

    Nov 1, 2015, 00:00
  • The 5-Years European Price Stability Awarded to Innovative Medicines- Is It Verified In Practice?

    Nov 1, 2015, 00:00
  • National Survey of Behavior, Attitudes and Practice of General Practitioners and Various Specialists Concerning Antimicrobial Use And Resistance in Respiratory Tract Infections

    Nov 1, 2015, 00:00
  • Pangaea 2.0- State Of The Art Multiple Sclerosis Patient Management In Daily Clinical Practice. A New 3-Year Observational Study Of Patients Receiving Fingolimod

    Nov 1, 2015, 00:00
  • Abobotulinumtoxin A In The Management of Cervical Dystonia In The United Kingdom- A Cost-Effectiveness Analysis

    Nov 1, 2015, 00:00
  • Time Trade-Off Utility Values in Mild and Severe Primary Dysmenorrhea

    Nov 1, 2015, 00:00
  • Ambulatory Medicines Cost With Transthyretin Familial Amyloid Polyneuropathy In Portugal

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Of Deep Brain Stimulation (Dbs) In The Management Of Advanced Parkinson’s Disease- A Swedish Payer Perspective

    Nov 1, 2015, 00:00
  • A Budget Impact Model Estimating the Financial Impact of Increased Use of Generic Bortezomib Intravenous (Iv) in the Treatment of Relapsed/Refractory Multiple Myeloma (Mm) in Venezuela

    Nov 1, 2015, 00:00
  • Diabetes Conversation Maps and Health Outcomes- A Systematic Literature Review

    Nov 1, 2015, 00:00
  • Do We Need to Strengthen Study Design in Observational Studies?

    Nov 1, 2015, 00:00
  • Beliefs About Medicines In An Urban Community Health Center Hypertension Population

    Nov 1, 2015, 00:00
  • TREATMENT STRATEGIES FOR ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA- A META-ANALYSIS AND INDIRECT TREATMENT COMPARISON

    Nov 1, 2015, 00:00
  • Considerations for the Adoption of the who-Choice Cost-Effectiveness Threshold in Latin America

    Nov 1, 2015, 00:00
  • Value Of Implementation Of Physical Exercise For Cancer Survivors

    Nov 1, 2015, 00:00
  • Assessing the Cost-Effectiveness of Antiretroviral Treatments in Hiv- an Individual Patient Simulation Approach

    Nov 1, 2015, 00:00
  • Association of Adverse Events And Health Service Usage With Tapentadol Prolonged-Release Treatment Compared With Morphine Controlled-Release (Cr) And Oxycodone Cr- A Uk Primary Care Observational Study

    Nov 1, 2015, 00:00
  • Cost Of Multimorbidity- The Influence Of Ambulatory Pharmaceutical And Hospital Expenditure

    Nov 1, 2015, 00:00
  • The German Amnog Drug Reimbursement Process- Factors Associated With Gba-Decisions About The Additional Benefit

    Nov 1, 2015, 00:00
  • Modelled U.K. And U.S. Analyses Demonstrate Sherlock 3cg® Tip Confirmation System For Peripherally Inserted Central Catheter Placement Is Associated With Favourable Health Economic Outcomes

    Nov 1, 2015, 00:00
  • The Economic Impact of an Hypothetical Rx-To-otc Switch in Spain

    Nov 1, 2015, 00:00
  • Assessment Of Patient-Reported Health Status In Pulmonary Arterial Hypertension Patients Treated With Riociguat- 2-Year Results From The Patent-2 Extension Study

    Nov 1, 2015, 00:00
  • Japanese Population Norms for Preference-Based Measures- Eq-5d-3l, Eq-5d-5l, And Sf-6d

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of New Therapies for Multiple Sclerosis In Spain

    Nov 1, 2015, 00:00
  • Prevalence of Acne Vulgaris in Europe and Impact of Lifestyle Factors

    Nov 1, 2015, 00:00
  • Análisis De Impacto Presupuestal De Detemir En Pacientes Diabéticos Tratados Con Insulinas Análogas

    Nov 1, 2015, 00:00
  • Study on Cost-Effectiveness Analysis For Ulcerative Colitis Treatment- A Systematic Review of Literature From 2004-2014

    Nov 1, 2015, 00:00
  • Have Infliximab Discounted Prices in Norway Had an Impact on Prices Around the World?

    Nov 1, 2015, 00:00
  • Impact of Pain Severity on Patient-Reported Outcomes of Individuals With Chronic Lower Back Pain In Japan

    Nov 1, 2015, 00:00
  • Impact Of Nocturia On Quality Of Life – Mapping Of Sf-12 To Utility Values Using Clinical Trial Data

    Nov 1, 2015, 00:00
  • Societal Burden And Impact On Health Related Quality Of Life (Hrqol) Of Non-Small Cell Lung Cancer (Nsclc) In Europe

    Nov 1, 2015, 00:00
  • Hllkj

    Nov 1, 2015, 00:00
  • Improvements in Patient-Reported outcomes Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in Dmard-Naive Patients with Severe, Active and Progressive Rheumatoid Arthritis- Results from the C-Early Ra ...

    Nov 1, 2015, 00:00
  • Patient Preferences for Attributes of Type 2 Diabetes Mellitus (T2dm) Treatments In Spain

    Nov 1, 2015, 00:00
  • Reduction In C-Reactive Protein With Biologic Drugs In Rheumatoid Arthritis and Spondylitis Patients In German Rheumatologist Practices

    Nov 1, 2015, 00:00
  • Applying Karnofsky Performance Scale In Hospitalized Patients For Promoting Rational Therapy

    Nov 1, 2015, 00:00
  • Comparative Efficacy Of Ketamine And Other Pharmacological And Somatic Interventions In Adult Patients With Treatment-Resistant Depression- A Network Meta-Analysis

    Nov 1, 2015, 00:00
  • Disproportionality Measures Used in Signal Detection- An Assessment on Pharmacovigilance Adverse Event Reporting System Data

    Nov 1, 2015, 00:00
  • The Importance of the Communicator for an Integrated Care Program - A Comparative Preference Analysis with Discrete Choice Experiments

    Nov 1, 2015, 00:00
  • Health States Worse Than Dead In An Elderly Population – Prevalence and The Significance of Chronic Pain

    Nov 1, 2015, 00:00
  • Relationship between Glycaemic Burden and Micro- and Macrovascular Complications in Patients with Type 2 Diabetes Mellitus- A real-world study in the Pharmo Database Network

    Nov 1, 2015, 00:00
  • Costo Efectividad De Múltiples Alternativas Diagn”Sticas En Pacientes Con Sospecha De Cáncer De Pulm”N En Colombia

    Nov 1, 2015, 00:00
  • Contrasting Model Predicted Life Expectancy In Patients With Type 2 Diabetes Across Different Mortality Risk Prediction Models Versus Data From The Canadian Chronic Disease Surveillance System

    Nov 1, 2015, 00:00
  • The Assessment Of Value For Medical Devices- A Case Study On Injection Technique Education In Insulin Delivery

    Nov 1, 2015, 00:00
  • Knowledge On Breast Cancer Among Women In Tolna And Baranya Counties, Hungary

    Nov 1, 2015, 00:00
  • Quality of Life Instruments used to Measure Job-Related Stress- a Systematic Review

    Nov 1, 2015, 00:00
  • Results of the Eq-5d-3l Valuation Project for Ireland

    Nov 1, 2015, 00:00
  • Intravitrael Aflibercept Injection for The Treatment of Visual Impairment Due to Macular Oedema Secondary to Branch Retinal Vein Occlusion- Cost-Effectiveness Versus Ranibizumab

    Nov 1, 2015, 00:00
  • The Relationship Between Glucose-Lowering Medications, Adherence, and Outcomes in Patients with Type 2 Diabetes

    Nov 1, 2015, 00:00
  • The Comparative Pharmacoeconomic Analysis Of Using Different Variants Of Balanced Crystalloids During Infusion Therapy

    Nov 1, 2015, 00:00
  • Comparative Analysis of Expenditure of Drugs for Malignancy

    Nov 1, 2015, 00:00
  • Cost-Utility Analysis of Continuous Infusion Pump With Integrated Monitoring Compared With Multiple Daily Injection Treatment for Patients 15-Years or Older With Type 1 Diabetes Mellitus In Colombia

    Nov 1, 2015, 00:00
  • Profile of Colorectal Cancer Treatment Within The Brazilian Public Setting- Analysis Of Datasus Aq Database

    Nov 1, 2015, 00:00
  • Building a Real World Data Network to Support Access to Oncology Medicines in Fran the Personalised Reimbursement Models Initiative

    Nov 1, 2015, 00:00
  • Methodological Changes In Burden of Infectious Disease Estimation- The Case of Pneumococcal Infection In Colombia

    Nov 1, 2015, 00:00
  • The Cost-Effectiveness of Canagliflozin (CANA) Versus Dapagliflozin (Dapa) 10mg and Empagliflozin (EMPA) 25mg in Patients with Type 2 Diabetes Mellitus (T2DM) as Monotherapy in the United Kingdom

    Nov 1, 2015, 00:00
  • Real World Skin Clearance Rates for Biologic Treatments In Patients With Moderate to Severe Plaque Psoriasis- Interim Results From A Large Prospective, Observational Study

    Nov 1, 2015, 00:00
  • Network Meta-Analysis (NMA) to Assess Relative Efficacy Measured as Percentage of Patients Treated to HbA1c Target with Canagliflozin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled on Metformin and Sulphonylurea (M ...

    Nov 1, 2015, 00:00
  • Health State Utilities Associated With Attributes of Weekly Injection Devices for Treatment of Type 2 Diabetes

    Nov 1, 2015, 00:00
  • The Effectiveness of Cbl Gene Mutation Test for Diagnosis In Juvenile Myelomonocytic Leukemia- Systematic Reviews

    Nov 1, 2015, 00:00
  • Evaluating the Safety Impact of Light Emitting Diode (LED) Guided Drug Picking in an Outpatient Pharmacy

    Nov 1, 2015, 00:00
  • Systematic Literature Review (Slr) And Network Meta-Analysis (Nma) Of Tenofovir/Emtricitabine (Tdf/Ftc) And Abacavir/Lamivudine (Abc/3tc) Backbone Regimens For Hiv-1

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis For Cervical Cancer Screening Using Hpv Tests In Brazil

    Nov 1, 2015, 00:00
  • The Opportunities Of Internet Technology And Telemedicine In Interaction Between Doctor And Patient

    Nov 1, 2015, 00:00
  • Patient-Reported Outcomes within Health Technology Assessment Decision Making- Current Status and Implications for Future Policy

    Nov 1, 2015, 00:00
  • The Burden of Rheumatoid Arthritis in Russia

    Nov 1, 2015, 00:00
  • Investigating The Impact of Contemporary Risk Factors for Diabetes Complications and Their Evolution on Risk Prediction Using The Ukpds 82 Equations

    Nov 1, 2015, 00:00
  • Impact of Poverty on Multidimensional Infant Mortality Rate In Brazil

    Nov 1, 2015, 00:00
  • A Systematic Review and Taxonomy of Economic Evaluations of Pharmaceuticals Licensed on The Basis of Uncontrolled Clinical Studies

    Nov 1, 2015, 00:00
  • Estimación de Cambios en la Calidad de Vida Debido al Uso de Ocriplasmina en Pacientes Con Tracción Vitreomacular en Colombia

    Nov 1, 2015, 00:00
  • Prevalnce of Cigrate Smooking And Allied Tobacco Products Among Universty Students In Quetta, Pakistan

    Nov 1, 2015, 00:00
  • Comparing Resource Use In Alzheimer’s Disease Across Three European Countries - 18-Month Results of The Geras Study

    Nov 1, 2015, 00:00
  • The Addition Of A Novel Colonoscope Device Improves Adenoma Detection In A German Screening Population Which May Result In Cost Savings Due To Fewer Cases Of Colorectal Cancer

    Nov 1, 2015, 00:00
  • Manufacturers’ Reactions in Response to the New Requirement for Cost-Effectiveness in France

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Patients With Chronic Hcv in the Netherlands

    Nov 1, 2015, 00:00
  • Survival and Rehospitalization After a First Hospitalization for Heart Failure- a Nationwide Population-Based Cohort Study using the French Egb Database

    Nov 1, 2015, 00:00
  • Reliability Of Manufacturers’ Budget Impact Estimates For Elimination Diet In Patients With Allergy To Cow’s Milk In Poland

    Nov 1, 2015, 00:00
  • Is The Proof of an Additional Benefit under amnog in Germany More Difficult for Certain Drugs than for Other Ones?

    Nov 1, 2015, 00:00
  • Early Stage Economic Evaluation of Caretoy System for Early Intervention In Preterm Infants At Risk of Neurodevelopmental Disorders

    Nov 1, 2015, 00:00
  • Application Of Asco Value Framework Evaluations Of Net Health Benefit For Oncology Drugs Launched In The United States Between 2013 And 2015

    Nov 1, 2015, 00:00
  • Payer Vs. Industry Views on Managed Entry Agreements

    Nov 1, 2015, 00:00
  • Evaluacion Economica De Leuprorelina 45 Mg En El Tratamiento De Cáncer De Prostata Avanzado

    Nov 1, 2015, 00:00
  • Reduction in Costs over two years when Treating with Darunavir/Ritonavir Compared to Atazanavir/Ritonavir in the UK

    Nov 1, 2015, 00:00
  • A Systematic Literature Review of Risk Prediction Models for Mortality, Complications and Diabetes Outcomes After Bariatric Surgery

    Nov 1, 2015, 00:00
  • Probiotics Significantly Reduce Mortality In Preterm Newborns With Necrotising Enterocolitis- Results of Large Network Meta-Analysis

    Nov 1, 2015, 00:00
  • Recommendations for Analysis of Patient Reported Outcomes (Pro) Efficacy Data When Evaluating Treatment Benefit

    Nov 1, 2015, 00:00
  • Nutritional Aspects And Disinformation In Liver Disease- A Questionnaire-Based Survey In Italian Patients

    Nov 1, 2015, 00:00
  • Cost of Early Retirement Caused By Rheumatic Diseases In Portugal

    Nov 1, 2015, 00:00
  • Evaluation of The Annual Cost of Fixed-Dose Combination Drugs Used In Treatment of Hypertension In India- An Economic Perspective

    Nov 1, 2015, 00:00
  • Evaluacion Economica De Los Principales Esteroides Intranasales Utilizados Para El Tratamiento De Pacientes Pediatricos Con Rinitis Alergica En Colombia

    Nov 1, 2015, 00:00
  • Evaluation of Inhaler Perception and Preference of Spiromax®, Easyhaler®, And Turbuhaler® Devices (Finhaler)

    Nov 1, 2015, 00:00
  • The Effectiveness Of Wide Field Fluorescein Angiography - Systematic Reviews

    Nov 1, 2015, 00:00
  • Change In The Demographic Profile And Impact In The Mortality Of Melanoma And Lung Cancer In Puerto Rico 2000-2010

    Nov 1, 2015, 00:00
  • Economical and Organizational Impact of Adopting Different in Situ Hybridization Technologies to Assess HER2 Gene Amplification in Breast Cancer

    Nov 1, 2015, 00:00
  • Analytical Representation of Utility Functions for Cervical Screening Strategies In Their Evaluation With “Cost-Utility” Method

    Nov 1, 2015, 00:00
  • Hiv Patient Preferences for Simplified Treatment Regimens

    Nov 1, 2015, 00:00
  • Condiçoes Socioeconomicoculturais Das Famílias de Indivíduos Nascidos Com Fissura Labiopalatina

    Nov 1, 2015, 00:00
  • Sistematic Review on Personal Predictors of Adherence to Medication. The Cumple-Q Scale

    Nov 1, 2015, 00:00
  • Dabigatran For The Treatment And Secondary Prevention Of Venous Thromboembolism

    Nov 1, 2015, 00:00
  • Clinical-Economic Modeling Analysis Of Human Papillomavirus (Hpv) Co-Testing With Genotyping Versus Primary Hpv Testing For Cervical Cancer Screening

    Nov 1, 2015, 00:00
  • Prevalência da Espondilite Anquilosante- Uma Revisão Sistemática

    Nov 1, 2015, 00:00
  • An Analysis of Medicine Procurement for Alzheimer’s Disease in Brazil From Federal Purchases

    Nov 1, 2015, 00:00
  • Calibration of Piecewise Markov Models Using a Change-Point Analysis Through an Iterative Convex Optimization Algorithm

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis of Vildagliptin vs. Glimepiride as Add-On to Metformin in the Management of Type 2 Diabetes Mellitus in Greece

    Nov 1, 2015, 00:00
  • Turkish Reimbursement System For Medical Devices

    Nov 1, 2015, 00:00
  • «
  • 91
  • 92 (current)
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • »